NECI Named On CRISPR Therapeutics ISPE FOYA Award, Third FOYA Contribution In Four Years
December 20, 2022
NECI contributed to the CRISPR facility's success by supplying its automation and control systems. This marks the third time in four years that NECI has contributed to a FOYA award-winning facility.
Read More